AR226806A1 - PROCEDURE FOR THE PREPARATION OF 3,20-DIOXO-7 ALPHA-HALO-4-PREGNENE AND-1,4-PREGNADIENE - Google Patents

PROCEDURE FOR THE PREPARATION OF 3,20-DIOXO-7 ALPHA-HALO-4-PREGNENE AND-1,4-PREGNADIENE

Info

Publication number
AR226806A1
AR226806A1 AR270418A AR27041877A AR226806A1 AR 226806 A1 AR226806 A1 AR 226806A1 AR 270418 A AR270418 A AR 270418A AR 27041877 A AR27041877 A AR 27041877A AR 226806 A1 AR226806 A1 AR 226806A1
Authority
AR
Argentina
Prior art keywords
pregnadiene
pregnene
dioxo
halo
alpha
Prior art date
Application number
AR270418A
Other languages
Spanish (es)
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/753,257 external-priority patent/US4076708A/en
Application filed by Scherico Ltd filed Critical Scherico Ltd
Application granted granted Critical
Publication of AR226806A1 publication Critical patent/AR226806A1/en

Links

Classifications

    • E—FIXED CONSTRUCTIONS
    • E04—BUILDING
    • E04G—SCAFFOLDING; FORMS; SHUTTERING; BUILDING IMPLEMENTS OR AIDS, OR THEIR USE; HANDLING BUILDING MATERIALS ON THE SITE; REPAIRING, BREAKING-UP OR OTHER WORK ON EXISTING BUILDINGS
    • E04G11/00—Forms, shutterings, or falsework for making walls, floors, ceilings, or roofs
    • E04G11/06—Forms, shutterings, or falsework for making walls, floors, ceilings, or roofs for walls, e.g. curved end panels for wall shutterings; filler elements for wall shutterings; shutterings for vertical ducts
    • E04G11/20—Movable forms; Movable forms for moulding cylindrical, conical or hyperbolical structures; Templates serving as forms for positioning blocks or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0084—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkylene group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • E—FIXED CONSTRUCTIONS
    • E04—BUILDING
    • E04G—SCAFFOLDING; FORMS; SHUTTERING; BUILDING IMPLEMENTS OR AIDS, OR THEIR USE; HANDLING BUILDING MATERIALS ON THE SITE; REPAIRING, BREAKING-UP OR OTHER WORK ON EXISTING BUILDINGS
    • E04G17/00—Connecting or other auxiliary members for forms, falsework structures, or shutterings
    • E04G17/14—Bracing or strutting arrangements for formwalls; Devices for aligning forms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Architecture (AREA)
  • Mechanical Engineering (AREA)
  • Civil Engineering (AREA)
  • Structural Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AR270418A 1976-12-22 1977-12-19 PROCEDURE FOR THE PREPARATION OF 3,20-DIOXO-7 ALPHA-HALO-4-PREGNENE AND-1,4-PREGNADIENE AR226806A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75325676A 1976-12-22 1976-12-22
US05/753,257 US4076708A (en) 1976-12-22 1976-12-22 Process for the preparation of 7α-halogeno-3-oxo-4-dehydro steroids and novel 7α-halogeno derivatives produced thereby

Publications (1)

Publication Number Publication Date
AR226806A1 true AR226806A1 (en) 1982-08-31

Family

ID=27115720

Family Applications (1)

Application Number Title Priority Date Filing Date
AR270418A AR226806A1 (en) 1976-12-22 1977-12-19 PROCEDURE FOR THE PREPARATION OF 3,20-DIOXO-7 ALPHA-HALO-4-PREGNENE AND-1,4-PREGNADIENE

Country Status (20)

Country Link
JP (1) JPS604198B2 (en)
AR (1) AR226806A1 (en)
AT (2) AT373269B (en)
BE (1) BE862089A (en)
DE (1) DE2756550C2 (en)
DK (1) DK153494C (en)
FI (1) FI63947C (en)
FR (1) FR2384793A1 (en)
GB (1) GB1575983A (en)
HK (1) HK584A (en)
HU (1) HU179784B (en)
IE (1) IE45950B1 (en)
IL (1) IL53636A (en)
MY (1) MY8500082A (en)
NL (1) NL180479C (en)
NO (1) NO151826C (en)
NZ (1) NZ186031A (en)
PT (1) PT67432B (en)
SE (1) SE429865B (en)
SG (1) SG58683G (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109680036A (en) 2017-10-02 2019-04-26 爱科来株式会社 The measurement of glycated proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3429926A (en) * 1964-05-25 1969-02-25 Squibb & Sons Inc 7-halo and 6-halo,6-dehydro a-norprogesterones

Also Published As

Publication number Publication date
FR2384793A1 (en) 1978-10-20
MY8500082A (en) 1985-12-31
DE2756550C2 (en) 1986-10-16
JPS604198B2 (en) 1985-02-01
NL180479C (en) 1987-03-02
FI63947B (en) 1983-05-31
NL180479B (en) 1986-10-01
HU179784B (en) 1982-12-28
SE7714538L (en) 1978-06-23
SE429865B (en) 1983-10-03
NL7714056A (en) 1978-06-26
FR2384793B1 (en) 1981-11-13
SG58683G (en) 1985-01-11
FI63947C (en) 1983-09-12
IE45950B1 (en) 1983-01-12
NO151826B (en) 1985-03-04
IE45950L (en) 1978-06-22
DK569977A (en) 1978-09-28
JPS5379850A (en) 1978-07-14
HK584A (en) 1984-01-13
PT67432B (en) 1979-05-23
AT373269B (en) 1984-01-10
AT377566B (en) 1985-04-10
IL53636A0 (en) 1978-03-10
ATA909477A (en) 1983-05-15
ATA575980A (en) 1982-04-15
DK153494C (en) 1989-02-20
DK153494B (en) 1988-07-18
NO774359L (en) 1978-06-23
GB1575983A (en) 1980-10-01
PT67432A (en) 1978-01-01
NO151826C (en) 1985-06-12
NZ186031A (en) 1984-07-31
FI773825A (en) 1978-06-23
IL53636A (en) 1983-05-15
DE2756550A1 (en) 1978-07-06
BE862089A (en) 1978-06-20

Similar Documents

Publication Publication Date Title
AR215000A1 (en) PROCEDURE FOR THE PREPARATION OF C-076
AR222007A1 (en) PROCEDURE FOR THE PREPARATION OF NEW HENTRIACONTAPEPTIDOS
MX6046E (en) PROCEDURE FOR THE PREPARATION OF 4,5-DIARIL-2-NITRO-IMIDAZOLES
ES496442A0 (en) A PROCEDURE FOR THE PREPARATION OF 2,4-DIAMINOQUINAZOLINE DERIVATIVES
MX4089E (en) IMPROVED PROCEDURE FOR THE PREPARATION OF N-PHOSPHONOMETILGLICINA
AR224095A1 (en) PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF DITIOL-1,2 TIONA-3
AR220683A1 (en) PROCEDURE FOR THE PREPARATION OF M-PHENOXYBENZALDEHYDE
AR220684A1 (en) METHOD FOR THE PREPARATION OF 1-PHENYL-3-AZABICICLO (3.1.0) HEXANS
AR215875A1 (en) PROCEDURE FOR THE PREPARATION OF META-PHENOXY-BENZALDEHYDE
MX6242E (en) PROCEDURE FOR THE PREPARATION OF 1,2,3,5, TETRAHIDROIMIDAZOTIENOPIRIMIDIN-2-ONAS
AR211887A1 (en) PROCEDURE FOR THE PREPARATION OF ENDOLIZIN DERIVATIVES
MX4972E (en) IMPROVED PROCEDURE FOR THE PREPARATION OF 7 BETA-OXIIMMINO-ACILCEFALOSPORINAS
MX4664E (en) IMPROVED PROCEDURE FOR THE PREPARATION OF N-PHOSPHONOMETILGLYCIN DERIVATIVES
MX4820E (en) PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF 5,6-CIA AND-5,6-TRANS-10,19-DIHIDRO VITAMINA D
ES456483A0 (en) PROCEDURE FOR THE PREPARATION OF STYLBENE COMPOUNDS.
MX4796E (en) PROCEDURE FOR THE PREPARATION OF 2-IMINOTIAZOLINE DERIVATIVES
AR213430A1 (en) PROCEDURE FOR THE PREPARATION OF NEW N-CYANOALKYL-P-HALOPHENOXY-ISOBUTYRAMIDES
ES491683A0 (en) PROCEDURE FOR THE PREPARATION OF 1,3,7-TRIALQUILXANTINAS
RO75589A (en) PROCEDURE FOR THE PREPARATION OF 2,6-METHAN-2H-1-BENZOXOXINE
MX5685E (en) PROCEDURE FOR THE PREPARATION OF 4,5-DIARIL-2- (TIO-SUBSTITUTED) -PIRROL
AR217664A1 (en) PROCEDURE FOR THE PREPARATION OF OLEANDOMICINE DERIVATIVES
MX4750E (en) PROCEDURE FOR THE PREPARATION OF GAMMA-PIRONAS
AR230642A1 (en) PROCEDURE FOR THE PREPARATION OF AN INDOLEDIHIDROINDOLCARBOXAMIDE DIMERICA
MX147640A (en) PROCEDURE FOR THE PREPARATION OF COMPOUNDS OF 4 6-5-BETA-SULFATOETILSULFONIL-2-AMINO-PENOL
AR210207A1 (en) A PROCEDURE FOR THE PREPARATION OF NEW NICOTINOYLAMINE TRIACINES